BioSpace News Archive

Drug Development

Positive Data from Trovagene Phase 1b/2 Study of Onvansertib Featured in Oral Presentation at European Society for Medical Oncology (ESMO) Conference

Administration of onvansertib in combination with standard-of-care chemotherapy is safe and well-tolerated and resulted in anti-leukemic activity that appears to be sustainable over time

September 30, 2019
·
10 min read
Drug Development

Oragenics Presents Interim Data on The AG013 Phase 2 Clinical Trial at the European Society for Medical Oncology Congress 2019

Oragenics, Inc. announces initial data from its ongoing Phase 2, placebo-controlled, clinical trial of AG013 in oral mucositis presented in a poster session at the European Society for Medical Oncology Congress 2019 in Barcelona, Spain.

September 30, 2019
·
7 min read
Policy

Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927)

Moderna, Inc. announced the U.S. Food and Drug Administration has completed their review of the Investigational New Drug application for mRNA-3927, its investigational mRNA therapeutic for propionic acidemia and allowed it to proceed to clinic.

September 30, 2019
·
7 min read
Business

A2A Pharmaceuticals Appoints New Advisors

A2A Pharmaceuticals Inc., a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents, announced the formation of its advisory board.

September 30, 2019
·
4 min read
Business

RMS Medical Products Names R. John Fletcher Chairman of the Board

Repro Med Systems, Inc. dba RMS Medical Products announced that R. John Fletcher has been appointed Chairman of the Board.

September 30, 2019
·
3 min read
BioMidwest

Stericycle Study Finds Administering Insulin Injections in Public, Lack of Disposal Options Creates Unease Among American Diabetic Community

A quarter of Americans feel embarrassed, anxious to administer insulin in public; one in four are concerned about how to properly dispose of their needles/lancets

September 30, 2019
·
5 min read
BioCapital

Emmes Ranked as a Top Private Company

Company Offices in Rockville, Frederick and Tysons Corner Allow Employees to Choose a Location Closest to Home

September 30, 2019
·
1 min read
FDA

U.S. FDA Approves INVOKANA® (canagliflozin) to Treat Diabetic Kidney Disease (DKD) and Reduce the Risk of Hospitalization for Heart Failure in Patients with Type 2 Diabetes (T2D) and DKD

INVOKANA® is the only diabetes medicine indicated to slow the progression of diabetic nephropathy (also known as DKD) and reduce the risk of hospitalization for heart failure in patients with T2D and DKD

September 30, 2019
·
16 min read
Business

St. John Fisher College and 2U, Inc. Partner to Deliver New Hybrid Doctorate of Pharmacy

The St. John Fisher College Wegmans School of Pharmacy and 2U, Inc. announced a partnership to deliver a new clinically-oriented hybrid Pharm.D. pathway for aspiring pharmacy professionals in New York State and across the country.

September 30, 2019
·
4 min read
Jazz Pharmaceuticals Survey Highlights Prevalence of Misinformation and Misperception About Narcolepsy Among Americans

Jazz Pharmaceuticals announces findings from a consumer survey underscoring a need for better understanding of sleep disorders

September 30, 2019
·
8 min read